Insiders · HAE

Christopher Simon,

President & CEO, Director at Haemonetics Corp (HAE)

Christopher Simon, has filed 23 insider reports with the SEC since May 2021, as director at Sotera Health Co (SHC) and president & CEO and director at Haemonetics Corp (HAE). Christopher Simon, made no open-market purchases or sales in the last 12 months. The latest filing, on May 27, 2026, reports grant or award at Sotera Health Co (SHC).

Filings
23
Companies
2
Bought on market
None
Sold on market
$394K

Companies where Christopher Simon, is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sotera Health Co logo
SHC
Sotera Health Co
Directorsince August 202434,102$16.61May 27, 2026
Haemonetics Corp logo
HAE
Haemonetics Corp
President & CEO, Director444,704$394K$122.94May 19, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Christopher Simon, with

Other insiders at the same companies

Questions about Christopher Simon,

What is Christopher Simon,'s role at Haemonetics Corp?
Christopher Simon, reports to the SEC as president & CEO and director at Haemonetics Corp (HAE), according to the latest filing on May 19, 2026. Christopher Simon, has also filed as director at Sotera Health Co (SHC).
How many shares does Christopher Simon, own?
After the latest filing that states it, Christopher Simon, directly owned 34,102 shares of Sotera Health Co (SHC) and 444,704 shares of Haemonetics Corp (HAE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Christopher Simon, bought or sold stock recently?
The most recent open-market sale was on June 13, 2022: sold 1,148 shares of Haemonetics Corp (HAE) for $71.9K at an average of $62.60.
How do I get alerts when Christopher Simon, files?
Follow Christopher Simon, on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Simon, (SEC CIK 0001674993). Totals count each trade once, skipping amendments whose original is on file, from May 20, 2021 on. View on SEC EDGAR